Please login to the form below

Not currently logged in
Email:
Password:

JDRF names new CEO

Derek Rapp to lead diabetes research charity

The type 1 diabetes research charity JDRF has announced a change of leadership with the appointment of Derek Rapp as CEO.

The choice is a change of direction for Rapp, who was most recently mergers and acquisitions lead for the chemical firm Monsanto Company and has served as CEO of the start-up biotech Divergence.

He now finds himself at the helm of the largest research organisation trying to develop treatment options for type 1 diabetes. The move is not a complete surprise, however, as Rapp has been involved with the JDRF for some years since his son Turner was diagnosed with the condition in 2004.

“Derek has been a successful CEO of a biotechnology start-up, and recently served as a senior executive of a complicated, global biotechnology business,” said John Brady, chairman of the JDRF's board of directors.

“He combines a strong understanding of what JDRF needs at this pivotal time with the kind of managerial intellect we believe will ensure a seamless transition.”

Rapp replaces Jeffrey Brewer who announced his departure on Facebook.

Brewer's status update said: “New JDRF Board Chair notified me on Friday [July 18] that they'd like to go in a different leadership direction. So my role in the fight against T1D will necessarily change.”

“However, I'll still be committed to our shared mission. I'm proud to say I leave JDRF better positioned to pursue our mission. It's been an honour to lead JDRF, an organisation indispensable to the T1D community.”

Brady described Brewer as a “transformational CEO” whose work means the JDRF is “on the verge of life-changing breakthroughs”.

“His relentless passion to drive our artificial pancreas programme has truly earned him the moniker 'Father of the Artificial Pancreas',” added Brady, referencing the JDRF's work in researching a replacement pancreas to deliver insulin in people with type 1 diabetes.

22nd July 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics